It was demonstrated that the reduction in miR‐145 expression during aggressive meningiomas is related to increased cancer invasiveness and motility, while only minor reduction in the expression of miR‐145 targets has been observed, with COL5A1 most significantly down‐regulated in miR‐145‐positive cells. The gene discussed is COL5A1; the disease is cancer.